Regentis Biomaterials regentis.co.il


Public lists: Pharma Startups (6570)

Regentis Biomaterials is focused on developing and commercializing hydrogels for tissue regeneration. The Gelrin hydrogel platform is a matrix of polyethylene glycol diacrylate (PEG-DA) and denatured fibrinogen, combining the stability and versatility of a synthetic material with the bio-functionality of a natural substance for a range of clinical applications. The company's flagship product, GelrinC, for the treatment of articular cartilage lesions, is currently in clinical trials.

Regentis Biomaterials is focused on developing and commercializing hydrogels for tissue regeneration. The Gelrin hydrogel platform is a matrix of polyethylene glycol diacrylate (PEG-DA) and denatured fibrinogen, combining the stability and versatilit...Show all

Company (Alive / Active)

Phone: +972-4-6265502

Fax:

Northern Industrial Zone
12 Ha’ilan Street
Or Akiva, 3060000
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Regentis Biomaterials $32.5M Jan 9, 2019
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Regentis Biomaterials Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 12 investors

Competitors

Company Status Description Investors

BioMimetic Therapeutics

Franklin, Tennessee, United States
AcquiredBioMimetic Pharmaceuticals (BMTI) is a biopharmaceutical company focused on the development, commercialization and ultimate marketing of protein therapeutics for tissue and organ regeneration. The Company's lead technologies are for the healing and restoration of bone and other tissues. Its lead products are based on recombinant human platelet-derived growth factor BB (rhPDGF-BB). In March 2013, BioMimetic Therapeutics was acquired by Wright Medical Group. The valuation of BioMimetic Therapeuti...Show allLogin to see details

The DNA Repair Company

Boston, Massachusetts, United States
Alive / ActiveThe DNA Repair Company was founded to bring recent scientific discoveries from the Dana Farber Cancer Institute and the Massachusetts Institute of Technology to the clinic to benefit cancer patients. Breakthroughs in understanding DNA repair mechanisms have led to new personalized approaches to cancer treatment, beginning with diagnostic tools that improve the efficacy of currently available cancer therapies, as well as drugs under development. DNAR exists to make these tools available to physic...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Treatment of cavities in a human body Oct 06, 2014 Feb 20, 2018 Patent
Treatment of cavities in a human body Apr 06, 2015 Jan 23, 2018 Patent
Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same Aug 31, 2015 Jul 11, 2017 Patent
Compositions and methods for scaffold formation Apr 16, 2008 Apr 18, 2017 Patent
Pegylated fibrinogen precursor molecule Oct 13, 2014 Oct 25, 2016 Patent
See all 14 patents